Head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic CRPC
The importance of physical exercise to contribute to a lower risk of relapse in breast cancer
How were biosimilars discussed at ESMO 2017?
Combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
AURORA – seeking to understand the genetic aberrations in metastatic breast cancer